Morin v terapii ischemicko-reperfuzního poskození ledvinné tkáne laboratorního potkana
[Morin in the therapy of the ischemia-reperfusion damage model of the rat kidney]
Language Czech Country Czech Republic Media print
Document type English Abstract, Journal Article
PubMed
16570585
- MeSH
- Antioxidants therapeutic use MeSH
- Flavonoids therapeutic use MeSH
- Rats MeSH
- Kidney blood supply metabolism MeSH
- Kidney Diseases drug therapy metabolism MeSH
- Rats, Wistar MeSH
- Reperfusion Injury drug therapy metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Names of Substances
- Antioxidants MeSH
- Flavonoids MeSH
- morin MeSH Browser
The aim of this study was to analyze the protective effects of morin administered during the therapy of reperfusion injury of the laboratory rat kidney. Animals were randomly divided into five groups (n= 10). One group was left intact. Three medicated groups and one placebo group were subjected to ischemia (60 min) and reperfusion of the left kidney. Morin was suspended in a 2 ml of 0.5% Avicel solution and administered orally by a gastric probe at doses of 5, 10, and 20 mg.kg(-1) once a day for 15 days. The placebo group was given only 2 ml of 0.5% Avicel in the same way. On the 15th day, all the animals were exsanguinated and the reperfused kidneys were recovered. Selected biochemical markers in blood were assessed: superoxide dismutase, glutathion peroxidase, total antioxidative capacity, malondialdehyde, creatinine, urea, and uric acid. Creatinine, urea, and total protein were analyzed in urine, and a 24-hour diuresis was recorded. The kidney tissue samples were used for histopathological examination. Morin supported the organism's own defensive reactions against free radicals and decreased lipid peroxidation in the cell membranes and contributed to the recovery of kidney functions. The histopathological results confirm 20 mg x kg(-1) as the most effective dose.